Ocean Biomedical, Inc. Quarterly Operating Income (Loss) in USD from Q2 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Ocean Biomedical, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2021 to Q1 2024.
  • Ocean Biomedical, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$595K, a 89% increase year-over-year.
  • Ocean Biomedical, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$5.42M, a 66.9% increase year-over-year.
  • Ocean Biomedical, Inc. annual Operating Income (Loss) for 2023 was -$10.2M, a 36.6% increase from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$595K +$4.79M +89% Mar 31, 2024 10-Q 2024-12-23
Q4 2023 $660K +$1.6M Dec 31, 2023 10-K 2024-11-25
Q3 2023 -$2.66M +$518K +16.3% Sep 30, 2023 10-Q 2024-04-15
Q2 2023 -$2.83M +$4.07M +59% Jun 30, 2023 10-Q/A 2024-04-15
Q1 2023 -$5.39M -$277K -5.42% Mar 31, 2023 10-Q 2024-12-23
Q4 2022 -$938K Dec 31, 2022 10-K 2024-11-25
Q3 2022 -$3.17M -$3.13M -7328% Sep 30, 2022 10-Q 2024-04-15
Q2 2022 -$6.9M -$6.9M Jun 30, 2022 10-Q/A 2024-04-15
Q1 2022 -$5.11M Mar 31, 2022 10-Q/A 2024-04-15
Q3 2021 -$42.7K Sep 30, 2021 10-Q 2022-10-17
Q2 2021 -$82* Jun 30, 2021 10-Q 2022-07-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.